Grow Teeth With Urine !

Chinese researchers describe how stem cells derived from urine could be used to generate solid organs and tissues, including teeth. Their study is published this week in the open-access journal Cell Regeneration. The researchers hope the technique might one day help provide new, tailor-made teeth for dental patients. Previous stem cell research has shown how cells can be generated from urine. It is also known that cells discarded with urea can become induced pluripotent stem cells (iPSCs) that can then generate many different cell types, including neurons and heart muscle cells. Tissue culture breakthrough Duanqing Pei and his colleagues from Guangzhou Institutes of Biomedicine and Health, and other Chinese universities have developed a novel chimeric tissue culture system that can coax these iPSCs into tiny structures that resemble teeth. Their system mimics normal tooth development, which results from an interaction between two different cell types: epithelial cells, producing enamel, and mesenchymal cells, which generate the other three main tooth components of dentin, cementum and pulp. 
First, the team used chemicals to coax the cultured iPSCs into flat sheets of epithelial cells. They then mixed these cells with mouse embryonic mesenchymal cells, and transplanted them into mice. Three weeks later, formations had grown that physically and structurally resembled human teeth. They are of roughly the same elasticity, and contain pulp, dentin and enamel-forming cells. The hope for regenerative medicine Though these structures are a new achievement, the method involves mouse cells, has a success rate of just 30% and the structures produced are only about one-third as hard as human teeth. 
To resolve these issues, the team say human mesenchymal stem cells could be substituted for mouse ones and the tissue culture conditions tweaked. In theory, this revised method could create a bioengineered tooth bud, cultured in a jar and then transplanted into the jawbone of a human patient to form a fully functional tooth. 
iPSCs remain a great source of hope for regenerative medicine. Not only do they avoid the controversial use of embryos, but they also come from a more readily accessible source than even cultured skin and blood. Furthermore, cells generated by this method cannot be rejected by the human immune system, being derived from the host's own cellular material.

Invest In Implants

A report published as the lead article in the International Journal of Oral & Maxillofacial Implants shows that dental implants offer a cost-effective alternative to traditional treatments for tooth replacement. The report, which is also cited on PubMed, the US National Library of Medicine located at the National Institutes of Health, is based on a systematic review of all available studies published in English between 2000 and 2010 relating to the cost-effectiveness of various tooth-replacement options. In total, 14 studies on long-term costs were included in the final review, which yielded the following conclusions: For single-tooth replacement, implant-based solutions were generally cost-saving or cost-effective in comparison with traditional tooth-borne prostheses (bridges). For patients with full dentures, implant-borne solutions were associated with higher initial costs than traditional (non-fixed) dentures. However, the consensus of most studies was that, over the long term, dental implants represent a cost-effective treatment option. Additionally, patient acceptance, satisfaction, and willingness to pay for dental implants were high, particularly in elderly edentulous patients. A trend toward improved overall improved oral-health-related quality of life and decreased health care costs was also reported. A key objective of this review was to conduct an extensive literature search and to consolidate all the relevant findings into one document that could serve as a single point of reference for healthcare professionals and patients. The fact that it has been published by a leading peer-reviewed scientific journal endorses the quality of the authors' research .

Reduce Decay Using A New Toothpaste

Researchers have developed new degradable particles, about the same size as small holes in teeth, which are designed to enter these holes and physically block and repair decayed teeth. These particles are special glasses and can be incorporated into toothpaste and will dissolve in the mouth releasing calcium and phosphate that form tooth mineral. This reduces tooth pain, cuts back on the incidences of tooth decay and repairs teeth. This could bring relief to the estimated 20 million adults in UK (40 per cent of the UK adult population) who are prone to tooth sensitivity. Indeed, untreated tooth decay or cavities in permanent teeth is the most common of all 291 major diseases and injuries assessed in the latest Global Burden of Diseases study. It affects 35 per cent of the world's population. The team behind this development, led by Professor Robert Hill from Queen Mary, University of London have won the £25,000 materials science Venture Prize, awarded by the Worshipful Company of Armourers and Brasiers. "These new particles dissolve faster than existing ones and are also softer than tooth enamel," said Professor Hill. "They have a more expanded open structure and this allows water to go into the glass structure faster and the calcium and phosphate ions to come out faster. Also, while existing particles are significantly harder and abrade away the enamel during brushing, our new particles will be softer." Tooth pain is associated with hot, cold or mechanical stimulation and is caused by fluid flow within small tubes located within the tooth. These tubes can become exposed as a result of the gums receding, hence the expression "long in the tooth" or through the loss of the outer enamel coating as a result of tooth decay, acid erosion or mechanical wear associated with tooth brushing. These new bioactive particles can also re-mineralise the holes via the release of calcium and phosphate ions. "This is a hugely exciting development which could benefit millions of people not only throughout the UK and Europe but right across the world," said Professor Bill Bonfield, chairman of the Armourers & Brasiers Venture Prize judging panel. "It meets our aim to encourage innovative scientific entrepreneurship in the UK and provide funding, which is often difficult to source, to bring new materials science research like this to market." In addition to Professor Hill, who is head of dental physical sciences at Barts and the London School of Medicine and Dentistry, Queen Mary. The team comprises: Dr David Gillam clinical lecturer and dentist, Dr Natalia Karpukhina an expert on bioactive glasses and Dr Pushkar Wadke from Queen Mary Innovations. "This award will enable us to get our research from the laboratory into a prototype toothpaste, said Professor Hill. "The difficult step is getting money to enable the translation of research in the laboratory into commercial products. This is what the Venture Prize Award will enable us to do." This development has come at an appropriate time. The latest Global Industry Analysts report outlined that the total world market for toothpaste is forecast to reach US$12.6 billion (£8.1billion) by the year 2015. This increase it outlines will be led by product innovations, rising population levels and greater awareness about oral hygiene.